187 related articles for article (PubMed ID: 17593617)
1. Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers.
O'Driscoll L
Anticancer Res; 2007; 27(3A):1257-65. PubMed ID: 17593617
[TBL] [Abstract][Full Text] [Related]
2. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
Friel AM; Corcoran C; Crown J; O'Driscoll L
Breast Cancer Res Treat; 2010 Oct; 123(3):613-25. PubMed ID: 20549336
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic potential of circulating nucleic acids for oncology.
Goessl C
Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
[TBL] [Abstract][Full Text] [Related]
4. Possible common biomarkers from FTIR microspectroscopy of cervical cancer and melanoma.
Mordechai S; Sahu RK; Hammody Z; Mark S; Kantarovich K; Guterman H; Podshyvalov A; Goldstein J; Argov S
J Microsc; 2004 Jul; 215(Pt 1):86-91. PubMed ID: 15230879
[TBL] [Abstract][Full Text] [Related]
5. Circulating nucleic acids in plasma/serum.
Tsang JC; Lo YM
Pathology; 2007 Apr; 39(2):197-207. PubMed ID: 17454749
[TBL] [Abstract][Full Text] [Related]
6. Reverse-transcriptase polymerase chain reaction to detect extracellular mRNAs.
Rani S; O'Driscoll L
Methods Mol Biol; 2011; 784():15-25. PubMed ID: 21898210
[TBL] [Abstract][Full Text] [Related]
7. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis.
Chan AK; Chiu RW; Lo YM;
Ann Clin Biochem; 2003 Mar; 40(Pt 2):122-30. PubMed ID: 12662399
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
Payne SR; Serth J; Schostak M; Kamradt J; Strauss A; Thelen P; Model F; Day JK; Liebenberg V; Morotti A; Yamamura S; Lograsso J; Sledziewski A; Semjonow A
Prostate; 2009 Sep; 69(12):1257-69. PubMed ID: 19459176
[TBL] [Abstract][Full Text] [Related]
10. Recovering circulating extracellular or cell-free RNA from bodily fluids.
Tzimagiorgis G; Michailidou EZ; Kritis A; Markopoulos AK; Kouidou S
Cancer Epidemiol; 2011 Dec; 35(6):580-9. PubMed ID: 21514265
[TBL] [Abstract][Full Text] [Related]
11. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
Anderson JE; Hansen LL; Mooren FC; Post M; Hug H; Zuse A; Los M
Drug Resist Updat; 2006; 9(4-5):198-210. PubMed ID: 17011811
[TBL] [Abstract][Full Text] [Related]
12. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
Ohori M
Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
[TBL] [Abstract][Full Text] [Related]
13. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
14. Direct profiling of cancer biomarkers in tumor tissue using a multiplexed nanostructured microelectrode integrated circuit.
Fang Z; Soleymani L; Pampalakis G; Yoshimoto M; Squire JA; Sargent EH; Kelley SO
ACS Nano; 2009 Oct; 3(10):3207-13. PubMed ID: 19736919
[TBL] [Abstract][Full Text] [Related]
15. Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
Taback B; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932
[TBL] [Abstract][Full Text] [Related]
16. The footprints of cancer development: Cancer biomarkers.
Ullah MF; Aatif M
Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Sardana G; Jung K; Stephan C; Diamandis EP
J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
[TBL] [Abstract][Full Text] [Related]
18. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
19. Circulating nucleic acids in plasma and serum: recent developments.
Swaminathan R; Butt AN
Ann N Y Acad Sci; 2006 Sep; 1075():1-9. PubMed ID: 17108186
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
